375 related articles for article (PubMed ID: 33188876)
41. Cancer stem cell-driven efficacy of trastuzumab (Herceptin): towards a reclassification of clinically HER2-positive breast carcinomas.
Martin-Castillo B; Lopez-Bonet E; Cuyàs E; Viñas G; Pernas S; Dorca J; Menendez JA
Oncotarget; 2015 Oct; 6(32):32317-38. PubMed ID: 26474458
[TBL] [Abstract][Full Text] [Related]
42. Cancer stem cells: the 'Achilles heel' of chemo-resistant tumors.
Hong IS; Lee HY; Nam JS
Recent Pat Anticancer Drug Discov; 2015; 10(1):2-22. PubMed ID: 25479037
[TBL] [Abstract][Full Text] [Related]
43. Cancer stem cells (CSCs): metabolic strategies for their identification and eradication.
De Francesco EM; Sotgia F; Lisanti MP
Biochem J; 2018 May; 475(9):1611-1634. PubMed ID: 29743249
[TBL] [Abstract][Full Text] [Related]
44. Targeting Stemness: Implications for Precision Medicine in Breast Cancer.
Liang ZM; Chen Y; Luo ML
Adv Exp Med Biol; 2017; 1026():147-169. PubMed ID: 29282683
[TBL] [Abstract][Full Text] [Related]
45. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
Safa AR
Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
[TBL] [Abstract][Full Text] [Related]
46. Ciprofloxacin mediates cancer stem cell phenotypes in lung cancer cells through caveolin-1-dependent mechanism.
Phiboonchaiyanan PP; Kiratipaiboon C; Chanvorachote P
Chem Biol Interact; 2016 Apr; 250():1-11. PubMed ID: 26947806
[TBL] [Abstract][Full Text] [Related]
47. Cancer stem cells: the promise and the potential.
Ajani JA; Song S; Hochster HS; Steinberg IB
Semin Oncol; 2015 Apr; 42 Suppl 1():S3-17. PubMed ID: 25839664
[TBL] [Abstract][Full Text] [Related]
48. The challenge of targeting cancer stem cells to halt metastasis.
Agliano A; Calvo A; Box C
Semin Cancer Biol; 2017 Jun; 44():25-42. PubMed ID: 28323021
[TBL] [Abstract][Full Text] [Related]
49. EMT, CTCs and CSCs in tumor relapse and drug-resistance.
Mitra A; Mishra L; Li S
Oncotarget; 2015 May; 6(13):10697-711. PubMed ID: 25986923
[TBL] [Abstract][Full Text] [Related]
50. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
[TBL] [Abstract][Full Text] [Related]
51. PGE
Lin MC; Chen SY; He PL; Herschman H; Li HJ
Int J Cancer; 2018 Sep; 143(6):1440-1455. PubMed ID: 29658109
[TBL] [Abstract][Full Text] [Related]
52. Road to stemness in hepatocellular carcinoma.
Flores-Téllez TN; Villa-Treviño S; Piña-Vázquez C
World J Gastroenterol; 2017 Oct; 23(37):6750-6776. PubMed ID: 29085221
[TBL] [Abstract][Full Text] [Related]
53. Cancer Stem Cells and Targeting Strategies.
Barbato L; Bocchetti M; Di Biase A; Regad T
Cells; 2019 Aug; 8(8):. PubMed ID: 31426611
[TBL] [Abstract][Full Text] [Related]
54. Targeting Cancer Stem Cells Pathways for the Effective Treatment of Cancer.
Dwivedi AR; Thakur A; Kumar V; Skvortsova I; Kumar V
Curr Drug Targets; 2020; 21(3):258-278. PubMed ID: 31433755
[TBL] [Abstract][Full Text] [Related]
55. The strategies to cure cancer patients by eradicating cancer stem-like cells.
Mai Y; Su J; Yang C; Xia C; Fu L
Mol Cancer; 2023 Oct; 22(1):171. PubMed ID: 37853413
[TBL] [Abstract][Full Text] [Related]
56. Bone microenvironment signaling of cancer stem cells as a therapeutic target in metastatic prostate cancer.
Lee CH; Decker AM; Cackowski FC; Taichman RS
Cell Biol Toxicol; 2020 Apr; 36(2):115-130. PubMed ID: 31250347
[TBL] [Abstract][Full Text] [Related]
57. The cancer stem-cell signaling network and resistance to therapy.
Carnero A; Garcia-Mayea Y; Mir C; Lorente J; Rubio IT; LLeonart ME
Cancer Treat Rev; 2016 Sep; 49():25-36. PubMed ID: 27434881
[TBL] [Abstract][Full Text] [Related]
58. Inhibiting epidermal growth factor receptor signalling potentiates mesenchymal-epithelial transition of breast cancer stem cells and their responsiveness to anticancer drugs.
Manupati K; Dhoke NR; Debnath T; Yeeravalli R; Guguloth K; Saeidpour S; De UC; Debnath S; Das A
FEBS J; 2017 Jun; 284(12):1830-1854. PubMed ID: 28398698
[TBL] [Abstract][Full Text] [Related]
59. Approaches for targeting cancer stem cells drug resistance.
Rosa R; D'Amato V; De Placido S; Bianco R
Expert Opin Drug Discov; 2016 Dec; 11(12):1201-1212. PubMed ID: 27700193
[TBL] [Abstract][Full Text] [Related]
60. Cancer stem cells: an insight into the development of metastatic tumors and therapy resistance.
Nairuz T; Mahmud Z; Manik RK; Kabir Y
Stem Cell Rev Rep; 2023 Aug; 19(6):1577-1595. PubMed ID: 37129728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]